Aglaia Management B.V. Overview

  • Investor Type
  • Venture Capital
  • Status
  • Active
  • Professionals
  • 5
Professionals
  • Investments
  • 16
  • Portfolio
  • 8
  • Exits
  • 3
Exits

Aglaia Management B.V. General Information

Description

Founded in 2003, Aglaia Oncology Funds invests in early-stage oncology drug development companies. The firm has a proven track record in selecting and maturing early-stage breakthrough inventions that have the potential to transform cancer treatment. Through its Oncology Funds I and II, firm has invested in 12 early-stage companies; 6 were founded by Aglaia itself. Noteworthy investments include Syntarga, ISA Pharmaceuticals and Merus. The experienced team has been involved in the development of over 100 oncology products. The firm offers investors an opportunity to combine an attractive financial return with a meaningful impact on healthcare and society.

Contact Information

Formerly Known As
Aglaia Biomedical Ventures
Year Founded
2004
Investor Status
Will Consider New Projects
Primary Investor Type
Venture Capital
Primary Office
  • Businesspark Berg & Bosch
  • Professor Bronkhorstlaan 10, Building 92
  • 3723 MB Bilthoven
  • Netherlands
+31 030 000 0000

Aglaia Management B.V. Investments (16)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Inthera Bioscience 26-Jun-2018 Early Stage VC 000.00 Biotechnology Pre-Clinical Trials 0000 0000 00.0
0000000 11-Apr-2018 00000 00000 000.00 Biotechnology Generating Revenue 0000 000000
0000000000 000000 23-Aug-2017 00000 00000 000.00 Biotechnology Generating Revenue 0000 0000 00.0
0000000 0000000000 19-Jan-2017 00000 00000 000.00 Drug Discovery Clinical Trials - Phase 1 0000 0000 00.0
00000 000000000000 01-Apr-2016 00000 00000 Drug Discovery Generating Revenue 0000 0000000000
0000000 0000000000 14-Dec-2015 0000 00000 00.000 Biotechnology Pre-Clinical Trials 0000 0000 00.0
0000000 0000000000 29-Oct-2015 00000 00000 000.00 Biotechnology Product Development 0000 0000000000
00000 26-Aug-2015 00000 00000 0000 Drug Discovery Generating Revenue/Not Profitable 0000 0000 00.0
Merus 03-Oct-2013 Later Stage VC 000.00 Drug Discovery Generating Revenue/Not Profitable 0000 0000 00.0
ORCA Therapeutics 05-May-2013 Seed Round Drug Discovery Generating Revenue 0000 0000000000
You’re viewing 10 of 16 investments. Get the full list »
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Aglaia Management B.V. Exits (3)

Company Name Exit Date Exit Type Exit Size
Merus 19-May-2016 IPO 0000
00000000 23-Jun-2011 000000000000000000
000 00000000000000 000000000 00000000
To view Aglaia Management B.V.’s complete exits history, request access »

Aglaia Management B.V. Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Aglaia Management B.V. Team (17)

Name Title Deals Funds Boards Office
Karl Rothweiler Co-Founder & Partner 0 0 0 Bilthoven, Netherlands
Mark Krul Ph.D Co-Founder & Partner 0 0 0 Bilthoven, Netherlands
Eric Putten Partner 0 0 0 Bilthoven, Netherlands
Angelique Hermeling Office Manager Bilthoven, Netherlands
David Kerr Advisor Bilthoven, Netherlands
You’re viewing 5 of 17 team members. Get the full list »

Aglaia Management B.V. Co-Investors (16)

Name With Exits Lead Partner Series Industry
M Ventures 2 0 Series chart Industry bar
Novo Holdings 0 0 Series chart Industry bar
BioGeneration Ventures 0 0 Series chart Industry bar
Cancer Research UK 0 0 Series chart Industry bar
Oost NL 0 0 Series chart Industry bar
You’re viewing 5 of 16 co-investors. Get the full list »